Short sellers are pressing harder into Choice Hotels International even as the stock grinds higher, a divergence that makes this one of the more charged setups in hospitality right now.
The short position has been building steadily. Short interest reached 15.0% of free float on September 29, up 7.9% on the week and 17.1% over the past month. That is a meaningful and accelerating bet against a stock trading at $104.25 that has just posted a 3.9% weekly gain. The more telling signal is in the cost to borrow, which has tripled in a month. The rate climbed to 3.44% by September 29 from under 0.7% through most of August. The pace of that move is sharper than the level itself: borrow costs are up 188% on the week and 277% on the month. Alongside that, availability has tightened hard. It dropped to 32.8% by end of week from 91% on September 18, meaning there are now roughly three shares available to borrow for every ten already lent out. That is a compressed position relative to where it sat just two weeks ago, when supply was effectively unrestricted. ORTEX's short score backs this up at 82.7, a reading that ranks in the first percentile for the sector and has been climbing throughout September.
Options positioning cuts the other way. The put/call ratio fell to 0.84, well below its 20-day average of 1.10, and sits 1.36 standard deviations below that mean. That is a more call-heavy posture than usual, suggesting some participants are positioned for the stock to continue recovering rather than rolling over. The PCR has been drifting lower all week, from above 1.18 on September 21 to the current reading, a shift that coincides almost exactly with the stock's weekly recovery. So lending data points toward growing short conviction while options flow points toward near-term bullishness: the two sides are not in agreement.
The Street is roughly neutral. The consensus is hold, with nine analysts at that rating and a mean price target of $114.60, implying around 10% upside from here. The most recent action came from Baird yesterday, which kept its Outperform rating but trimmed its target by $1 to $128. Truist and UBS both raised targets modestly in September, keeping Buy and Neutral ratings respectively. Morgan Stanley remains at Underweight with a $91 target, the most bearish voice on the register, well below where the stock is now trading. Mizuho initiated in late August at Neutral with a $106 target, essentially at the current price. On valuation, the stock trades at a P/E of 14.1 and EV/EBITDA of 10.2, both nudging slightly higher over the past week in line with the price recovery. The dividend score ranks in the 86th percentile, though the dividend history in this dataset is stale and should not be relied upon for current yield.
Ownership tells a concentrated story. Baron Capital holds 20.9% of shares and added 1.6 million shares in the quarter ending June. The Bainum family, founders of the original company, collectively hold roughly 30% across three family members, none of whom have moved positions recently. Baron's continued accumulation at the top of the register is notable given that short sellers are simultaneously building a 15% short position. That is a tug of war between a major long-term institutional holder and a growing short base, both expressed at elevated scale. Morgan Stanley's 13G shows it trimmed from 7.6% to 6.3% as of August, while Kayne Anderson Rudnick cut from 6.4% to 2.0%, a significant reduction. Vanguard Group's last 13G showed a move to zero from 5.03%, though that filing was in March and positions may have shifted since. As with all 13D/G data, these are event-driven disclosures around the 5% threshold and holders can exit below that level without further filing.
Earnings land on November 5, five weeks away. The last print saw the stock add 1% on the day but give back nearly 3% over the following week. The prior result was a 3.6% one-day drop with a further 5.1% loss over five days. Nothing in the recent history suggests a reliably directional reaction, but the pattern leans modestly negative over the five-day window. Wikipedia traffic data shows retail attention running at a z-score of 2.1 relative to the prior 90 days as of September 8, indicating above-average interest in the name, though this dataset has not been measured to lead the company's financial figures.
The question heading into November is whether the short build reflects genuine fundamental skepticism about the company's ability to maintain its recovery, or whether it is a position that becomes increasingly costly to hold as borrow rates rise and the stock refuses to cooperate. The next catalyst to watch is the November 5 earnings print.
See the live data behind this article on ORTEX.
Open CHH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
